Mereo BioPharma Group Plc (MREO)

0.66 +0.09 (+16.34%) USD  |  NASDAQ  |  Jan 13, 16:00
0.74 +0.08 (+12.12%) After-Hours: 04:25
More

Mereo BioPharma Group Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for MREO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc --
NuCana Plc --
Autolus Therapeutics Plc Upgrade
Bicycle Therapeutics Plc Upgrade
Ultragenyx Pharmaceutical, Inc. Upgrade